Potentiality of Zinc phosphate@hydroxyapatite/β-cyclodextrin composites for cisplatin carrying: loading, release and cytotoxicity

May N. Bin Jumah,Sarah I. Al Othman,Awatif Abdulaziz Alomari,Ahmed Allam,Mostafa Ragab Abukhadra
DOI: https://doi.org/10.1039/d4nj01547a
IF: 3.3
2024-05-15
New Journal of Chemistry
Abstract:A zinc phosphate/hydroxyapatite composite (ZP/HAP) with a core-shell nano-rod morphology and its functionalized derivative with β-cyclodextrin (β-CD) were evaluated as potential carriers of the cisplatin drug (CPN). The developed CD@ZP/HAP displayed remarkably enhanced CPN loading properties (375.8 mg/g) compared to ZP/HAP (259.8 mg/g). The CPN loading behavior of CD@ZP/HAP followed Langmuir isotherm properties (R2 > 0.99) and the kinetic activities of the pseudo-first-order model (R2 > 0.97). The steric assessment validated the notable increase in existing loading receptors after the functionalization of ZP/HAP with β-CD from 57.7 mg/g (ZP/HAP) to 72.3 mg/g. Functionalization also affected the capacity of each receptor, ensuring that there were six CPN molecules (CD@ZP/HAP) instead of five (ZP/HAP), as well as the loading energies ( 0.45) reflected the release of CPN according to both erosion and diffusion mechanisms. The loading of CPN into both ZP/HAP and CD@ZP/HAP also resulted in a marked enhancement in the anticancer activity of CPN against human cervical epithelial malignancies (HeLa) (cell viability = 5.6% (CPN), 3.7% (CPN loaded ZP/HA), and 1.8% (CPN loaded CD@ZP/HAP))
chemistry, multidisciplinary
What problem does this paper attempt to address?